33797-34-1

Basic information

• Product Name: (3-Methoxy-2-methylphenyl)methanol
• Synonyms: (3-Methoxy-2-methylphenyl)methanol
• CAS NO: 33797-34-1
• Molecular Formula: C₉H₁₂O₂
• Molecular Weight: 152.19038
• Mol File: 33797-34-1.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 261.3±25.0 °C(Predicted)
• Appearance: /
• Density: 1.060±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.44±0.10(Predicted)
• CAS DataBase Reference: (3-Methoxy-2-methylphenyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-Methoxy-2-methylphenyl)methanol(33797-34-1)
• EPA Substance Registry System: (3-Methoxy-2-methylphenyl)methanol(33797-34-1)

Safety Data

• Hazardous Substances Data: 33797-34-1(Hazardous Substances Data)

Usage

General Description

(3-Methoxy-2-methylphenyl)methanol is a chemical compound with the molecular formula C9H12O2. It is a colorless liquid with a sweet, floral odor. (3-Methoxy-2-methylphenyl)methanol is often used as a fragrance ingredient in cosmetics, perfumes, and other personal care products. It can also be used as a solvent and as an intermediate in the synthesis of other organic compounds. The compound has low to moderate acute toxicity, with potential irritant effects on the skin and eyes. It is important to handle and use (3-Methoxy-2-methylphenyl)methanol with proper precautions to ensure safety.

Upstream product

• 56724-03-9 3-methoxy-2-methyl-benzaldehyde 
• 555-31-7 aluminum isopropoxide 
• 55289-06-0 3-methoxy-2-methylbenzoic acid 
• 42981-93-1 3-methoxy-2-methylbenzoic acid methyl ester 
• 1975-50-4 2-methyl-3-nitrobenzic acid 
• 55289-05-9 methyl 3-hydroxy-2-methylbenzoate 
• 603-80-5 3-hydroxy 2-methylbenzoic acid 
• 52130-17-3 3-amino-2-methylbenzoic acid 

Downstream Products

• 42981-94-2 1-(chloromethyl)-3-methoxy-2-methylbenzene 
• 270086-63-0 (3-methoxy-2-methyl-benzylsulfanyl)-acetic acid 
• 270086-39-0 (3-methoxy-2-methyl-benzylsulfanyl)-acetic acid ethyl ester 
• 94440-72-9 3-<3-Methoxy-2-methyl-benzyl>-2-methyl-4-oxo-cyclohexan-1-carbonsaeure-ethylester 
• 33797-36-3 2-(3-methoxy-2-methylphenyl)acetic acid 
• 33797-35-2 2-(3-methoxy-2-methylphenyl)acetonitrile 
• 51438-99-4 5-(m-Hydroxy-o-methylphenyl)-penten-1 
• 56724-03-9 3-methoxy-2-methyl-benzaldehyde 
• 1165923-81-8 2-(3-methoxy-2-methylphenyl)ethanamine 
• 1165923-89-6 1,1-dimethylethyl 6-hydroxy-5-methyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate 
• 1165923-91-0 1,1-dimethylethyl 5-methyl-6-{[(trifluoromethyl)sulfonyl]oxy}-3,4-dihydro-2(1H)-isoquinolinecarboxylate 
• 1258856-14-2 2-isopropoxy-5-(3-(6-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-1,2,4-oxadiazol-5-yl)benzonitrile trifluoroacetate 
• 1258856-15-3 tert-butyl 7-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-6-methyl-4,5-dihydro-1H-benzo[d]azepine-3(2H)-carboxylate 
• 1258853-83-6 (R)-5-(3-(3-(2,3-dihydroxypropyl)-6-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride 

Relevant articles and documents

Vanadium-Catalyzed Oxidative Intramolecular Coupling of Tethered Phenols: Formation of Phenol-Dienone Products

A mild and efficient method for the vanadium-catalyzed intramolecular coupling of tethered free phenols is described. The corresponding phenol-dienone products are prepared directly in good yields with low catalyst loadings. Electronically diverse tethered phenol precursors are well tolerated, and the catalytic method was effectively applied as the key step in syntheses of three natural products and a synthetically useful morphinan alkaloid precursor.

α-Ketocarbenium Ions Derived from Orthoquinone-Containing Polycyclic Aromatic Compounds

α-Ketocarbenium ions derived from synthesized orthoquinone-containing polycyclic aromatic compounds were generated in the presence of Br?nsted acids such as sulfuric acid, trifluoromethanesulfonic acid, and fluorosulfonic acid. The prepared α-ketocarbeniu

HETEROCYCLIC CARBOXYLIC ACIDS AS ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE

The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R5, R6, R7, R8, R9, B, V, W, X, Y, Z and m are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.